Skip to main content

View full-text article in PMC

. 2014 Mar 4;(3):1–115. doi: 10.1002/14651858.CD006404.pub2

Table 3.

Dosing regimens of artesunate-pyronaridine

Trial ID	Actual or target dose	Intervention(mg/kg/dose)		Comparator(mg/kg/dose)
Trial ID	Actual or target dose	Artesunate	Pyronaridine	Artemisinin-derivative	Partner drug
Kayentao 2012	Actual dose	2.2 to 4.4	6.7 to 13.3	1.3 to 4.0	8.0 to 24.0
Tshefu 2010	Target dose	2.4 to 4.6	7.2 to 13.8	NS	NS
Rueangweerayut 2012	Actual dose	2.4 to 4.7	7.1 to 14.0	2.5 to 5.0	6.2 to 12.5
Poravuth 2011	Target dose	2.4 to 4.6	7.2 to 13.8	—	10, 5, 5
Ringwald 1996	Target dose	—	16, 8, 8	—	10, 5, 5
Ringwald 1998	Target dose	—	8, 8, 8, 8	—	10, 10, 5

NS = Not specified.